2-Amino-7-(2-bromo-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one → 2-Amino-7-[2-(1H-indol-7-yl)-phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one
반응식
[NH2:1][C:2]1[N:11]=[C:10]([CH3:12])[C:9]2[C:8](=[O:13])[CH2:7][CH:6]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=3Br)[CH2:5][C:4]=2[N:3]=1.NC1N=[C:30]([CH3:32])[C:29]2[C:28](=O)[CH2:27][CH:26](C3C=CC=CC=3C3C=CC=CC=3)[CH2:25][C:24]=2[N:23]=1>>[NH2:1][C:2]1[N:11]=[C:10]([CH3:12])[C:9]2[C:8](=[O:13])[CH2:7][CH:6]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=3[C:25]3[CH:26]=[CH:27][CH:28]=[C:29]4[C:24]=3[NH:23][CH:32]=[CH:30]4)[CH2:5][C:4]=2[N:3]=1참가 물질
3
실험 절차
The title compound was prepared from 2-amino-7-(2-bromo-phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one (example 3/i stage 2/3), following the procedure describing the synthesis of 2-amino-7-biphenyl-2-yl-4-methyl-7,8-dihydro-6H-quinazolin-5-one (example 5/a stage 1) using 7-boronic acid-1H-indole instead of phenyl-boronic acid.
출처 및 근거
- ORD 기록
- ord-ff77f81f0d1b498fa43fffeb4b149a70